| Sep 27 |
Cue Biopharma prices $12M stock offering
|
| Sep 27 |
Cue Biopharma Announces Pricing of $12.0 Million Public Offering
|
| Sep 27 |
Cue Biopharma Announces Proposed Public Offering
|
| Sep 26 |
Cue biopharma announces proposed public offering
|
| Sep 9 |
Cue Biopharma Appoints Industry Veteran Lucinda Warren as Chief Business Officer
|
| Sep 3 |
Cue Biopharma to Present at The Promise of Interleukin-2 Therapy Conference
|
| Aug 20 |
Cue Biopharma, Inc. (CUE) Q2 2024 Earnings Call Transcript
|
| Aug 19 |
Cue Biopharma, Inc. 2024 Q2 - Results - Earnings Call Presentation
|
| Aug 19 |
Cue Biopharma GAAP EPS of -$0.20 beats by $0.04, revenue of $2.66M beats by $1.37M
|
| Aug 19 |
Cue Biopharma Reports Second Quarter 2024 Financial Results and Recent Business Highlights
|
